Early ART initiation among HIV-positive pregnant women in central Mozambique: a stepped wedge randomized controlled trial of an optimized Option B+ approach

James F Cowan, Mark Micek, Jessica F Greenberg Cowan, Manuel Napúa, Roxanne Hoek, Sarah Gimbel, Stephen Gloyd, Kenneth Sherr, James T Pfeiffer, Rachel R Chapman, James F Cowan, Mark Micek, Jessica F Greenberg Cowan, Manuel Napúa, Roxanne Hoek, Sarah Gimbel, Stephen Gloyd, Kenneth Sherr, James T Pfeiffer, Rachel R Chapman

Abstract

Background: Despite effective prevention strategies and increasing investments in global health, maternal to child transmission (MTCT) of HIV remains a significant problem globally, especially in sub-Saharan Africa. In 2012, there were 94,000 HIV-positive pregnant women in Mozambique. Approximately 15% of these women transmitted HIV to their newborn infants, resulting in nearly 14,000 new pediatric HIV infections that year. To address this issue, in 2013, the Mozambican Ministry of Health implemented the World Health Organization-recommended "Option B+" strategy in which all newly diagnosed HIV-positive pregnant women are counseled to initiate combination anti-retroviral therapy (ART) immediately upon diagnosis regardless of CD4 count and to continue treatment for life. Given the limited experience with Option B+ in sub-Saharan Africa, few rigorous pragmatic trials have studied this new treatment strategy.

Methods: This study utilizes an initial formative research process involving patient and health care provider interviews and focus groups, workforce assessments, value stream mapping, and commodity utilization assessments to understand the strengths and weaknesses in the current Option B+ care cascade. The formative research is intended to guide identification and prioritization of key workflow modifications and the development of an enhanced adherence and retention package. These two components are bundled into a defined intervention implemented and evaluated across six health facilities utilizing a stepped wedge randomized controlled trial study design. The overall objective of this trial is to develop and test a pilot intervention in central Mozambique to implement the new Option B+ guidelines with high fidelity and increase the proportion of HIV-positive pregnant women in target antenatal clinics (ANC) who start ART prior to delivery and are retained in care.

Discussion: This pragmatic study utilizes research strategies that have the potential to meaningfully improve the Option B+ care cascade in central Mozambique and to decrease the MTCT of HIV. This trial is designed to identify critical low-cost improvement strategies that can be bundled into a defined intervention. If this intervention has a measurable impact, it can be rapidly scaled up to other ANC in Mozambique and sub-Saharan Africa.

Trial registration: ClinicalTrials.gov: NCT02371265.

Figures

Figure 1
Figure 1
Map of Mozambique—provinces and provincial capitals [12].
Figure 2
Figure 2
Munhava health center PMTCT patient flow.
Figure 3
Figure 3
Aggregate flow cascade through seven health centers in Manica and Sofala provinces (2009).
Figure 4
Figure 4
Stepped wedge design of the implementation of test-and-treat intervention in PMTCT programs in central Mozambique.

References

    1. UNAIDS . Global report: report on the global AIDS epidemic. Geneva: UNAIDS; 2013.
    1. UNAIDS . The Gap report: children and pregnant women living with HIV. Geneva: UNAIDS; 2014.
    1. Conselho Nacional de Combate ao HIV e SIDA . Global AIDS response progress report: country progress report for Mozambique. Maputo, Mozambique: Conselho Nacional de Combate ao HIV e SIDA; 2014.
    1. UNAIDS. UNAIDS report on the global AIDS epidemic. 2010.
    1. WHO . Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Department of HIV/AIDS. Geneva, Switzerland: WHO; 2004.
    1. De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283:1175–82. doi: 10.1001/jama.283.9.1175.
    1. Dorenbaum A, Cunningham CK, Gelber RD, Culnane M, Mofenson L, Britto P, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288:189–98. doi: 10.1001/jama.288.2.189.
    1. Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29:484–94. doi: 10.1097/00126334-200204150-00009.
    1. Thorne C, Newell ML, Study EC. Are girls more at risk of intrauterine-acquired HIV infection than boys? AIDS. 2004;18:344–7. doi: 10.1097/00002030-200401230-00033.
    1. Buekens P, Curtis S, Alayón S. Demographic and health surveys: caesarean section rates in sub-Saharan Africa. BMJ. 2003;326:136. doi: 10.1136/bmj.326.7381.136.
    1. Sherman GG, Jones SA, Coovadia AH, Urban MF, Bolton KD. PMTCT from research to reality–results from a routine service. S Afr Med J. 2004;94:289–92.
    1. Jones SA, Sherman GG, Varga CA. Exploring socio-economic conditions and poor follow-up rates of HIV-exposed infants in Johannesburg. South Africa AIDS Care. 2005;17:466–70. doi: 10.1080/09540120412331319723.
    1. Manzi M, Zachariah R, Teck R, Buhendwa L, Kazima J, Bakali E, et al. High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. Trop Med Int Health. 2005;10:1242–50. doi: 10.1111/j.1365-3156.2005.01526.x.
    1. The World Bank . Mortality rate, under-5 (per 1,000 live births) Seattle, Washington: The World Bank; 2014.
    1. World Health Organization . Antiretroviral drugs for treating pregnant women and preventing HIV infections in infants: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2010.
    1. World Health Organization . Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants - Programmatic update. Geneva, Switzerland: WHO Document Production Services; 2012.
    1. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi. AIDS. 2014;28:589–98. doi: 10.1097/QAD.0000000000000143.
    1. Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng’ambi W, Bokosi M, et al. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe. Malawi Trop Med Int Health. 2014;19:1360–6. doi: 10.1111/tmi.12369.
    1. Pfeiffer J, Montoya P, Baptista AJ, Karagianis M, Pugas MM, Micek M, et al. Integration of HIV/AIDS services into African primary health care: lessons learned for health system strengthening in Mozambique - a case study. J Int AIDS Soc. 2010;13:3. doi: 10.1186/1758-2652-13-3.
    1. Ramers C, Lambdin B, Johnson W, Floriano F, Pfeiffer J, Micek M. The impact of HIV care decentralization on initiation of pre-natal anti-retroviral therapy in Central Mozambique. Abstract no. THPE0789. Vienna: International AIDS Society Conference; 2010.
    1. Fernandes QF, Wagenaar BH, Anselmi L, Pfeiffer J, Gloyd S, Sherr K. Effects of health-system strengthening on under-5, infant, and neonatal mortality: 11-year provincial-level time-series analyses in Mozambique. Lancet Glob Health. 2014;2:e468–77. doi: 10.1016/S2214-109X(14)70276-1.
    1. Mozambique Ministry of Health . 2009 National Survey on Prevalence, Behavioral Risks and Information about HIV and AIDS in Mozambique (INSIDA) Maputo, Mozambique: Mozambique Ministry of Health; 2009.
    1. Mozambique Ministry of Health . PMTCT 2009 Programme Report. Maputo, Mozambique: Mozambique Ministry of Health; 2009.
    1. Health Alliance International . Final Program Report, President’s Emergency Program for AIDS Relief (PEPFAR): Cooperative Agreement656-A-00-04-00021-00. Seattle, Washington: Health Alliance International; 2011.
    1. Mozambique Ministry of Health and the National Department of Medical Assistance . National Data Report: Antiretroviral Treatment. Maputo, Mozambique: Mozambique Ministry of Health and the National Department of Medical Assistance; 2011.
    1. Blanco A. Maternal characteristics and poor follow-up rates of HIV-exposed infants in Central Mozambique. School of Public Health: University of Washington; 2009.
    1. Thome B. HIV and prevention of mother to child transmission (PMTCT) in central Mozambique: community influences on loss to follow up. Seattle, Washington: University of Washington, School of Public Health; 2010.
    1. Chapman RTB, Johnson W. Reducing loss-to-follow-up in prevention of mother to child transmission of HIV (PMTCT) services: identifying facility and community-level factors associated with PMTCT abandonment in central Mozambique - Sofala Province. Seattle, Washington: Health Alliance International; 2010.
    1. Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7:44–51. doi: 10.1007/s11904-009-0037-5.
    1. Hussey MA, Hughes JP. Design and analysis of stepped wedge cluster randomized trials. Contemp Clin Trials. 2007;28:182–91. doi: 10.1016/j.cct.2006.05.007.
    1. Sherr K, Gimbel S, Rustagi A, Nduati R, Cuembelo F, Farquhar C, et al. Systems analysis and improvement to optimize pMTCT (SAIA): a cluster randomized trial. Implement Sci. 2014;9:55. doi: 10.1186/1748-5908-9-55.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren